Skip to main content
. Author manuscript; available in PMC: 2021 Mar 25.
Published in final edited form as: Mov Disord. 2019 Sep 30;35(1):171–176. doi: 10.1002/mds.27872

Table 1:

Demographic data


4RT Non-4RT
Total PSP CBD Total MSA PD T-neg. FTLD

N 250 195 55 161 50 51 60
M:F 132:118 102:93 30:25 82:79 16:34 25:26 41:19
(N, [%]) [53:47] [52:48] [55:45] [51:49] [32:68] [49:51] [68:32]
Age at onset 65.7±0.6 66.3±0.6 63.8±1.2 58.2±0.7 59.7±1.3 58.7±1.5 56.8±1.0
(yrs., mean±S.E.M [range]) [41–91] [41–91] [42–81] [42–80] [45–80] [42–76] [42–74]
Age at death 73.3±0.6 74.1±0.6 70.4±1.2 67.7±0.7 67.1±1.2 73.4±1.2 63.5±1.2
(yrs., mean±S.E.M [range]) [51–94] [54–94] [51–85] [47–92] [51–90] [59–92] [47–84]
Disease duration 7.5±0.3 7.7±0.3 6.7±0.4 9.3±0.5 7.4±0.3 14.7±1.0 6.7±0.6
(yrs., mean±S.E.M [range]) [0–27] [0–27] [1–12] [1–35] [2–15] [3–35] [1–20]

Demographic data of all autopsy-confirmed patients, sub-grouped according to underlying pathology.